Executive Committee: ANGLE plc

Manager
Positions heldSince
Andrew Newland

Andrew Newland

63 year

Chief Executive Officer 31/03/1994
Founder 31/03/1994
Ian Griffiths

Ian Griffiths

Director of Finance/CFO 31/12/1994
Corporate Secretary 27/08/2009
Martin Cooke

Martin Cooke

Chief Operating Officer 31/12/2003
General Counsel 31/12/2003
Anne-Sophie Pailhes-Jimenez

Anne-Sophie Pailhes-Jimenez

Chief Tech/Sci/R&D Officer 31/12/2019
Stefan Peter

Stefan Peter

Chief Tech/Sci/R&D Officer 30/06/2019
Karen Miller

Karen Miller

Chief Tech/Sci/R&D Officer 04/06/2023

Composition of the Board of Directors: ANGLE plc

Director
CommitteesSince
Jan Groen

Jan Groen

65 year

Audit Committee 21/05/2023
Nominating Committee 21/05/2023
Compensation Committee Chair 21/05/2023
Juliet Thompson

Juliet Thompson

57 year

Compensation Committee 04/01/2023
Nominating Committee 04/01/2023
Audit Committee Chair 04/01/2023
Governance Committee 23/03/2021
Brian Howlett

Brian Howlett

80 year

Audit Committee 06/01/2013
Compensation Committee 20/11/2013
Nominating Committee 20/11/2013
Joseph Eid

Joseph Eid

56 year

Compensation Committee 18/01/2023
Nominating Committee 18/01/2023
Ian Griffiths

Ian Griffiths

Director/Board Member 10/04/2011
Andrew Newland

Andrew Newland

63 year

Director/Board Member 14/11/2010

Former Officers and Directors: ANGLE plc

Insider
Positions held
SinceUntil
Madeline Repollet
Madeline Repollet
Corporate Officer/Principal 31/05/2020 30/11/2023
Craig Miller
Craig Miller
Chief Tech/Sci/R&D Officer 29/02/2016 30/11/2023
Garth Selvey
Garth Selvey
Director/Board Member 21/05/2023 29/09/2023
Chairman 31/08/2007 21/05/2023
Independent Dir/Board Member 06/09/2006 22/05/2023
Andrew Holder
Andrew Holder
Investor Relations Contact 31/12/2020 31/08/2023
Michael O'Brien
Michael O'Brien
Corporate Officer/Principal 31/10/2008 30/06/2023
Todd Druley
Todd Druley
Chief Tech/Sci/R&D Officer 14/11/2021 28/02/2022
Jay Lewington
Jay Lewington
Chief Tech/Sci/R&D Officer 31/12/2016 -
David Quysner
David Quysner
Director/Board Member 27/08/2009 29/09/2014
Independent Dir/Board Member 08/03/2004 29/09/2014
Eulian Roberts
Eulian Roberts
Corporate Officer/Principal 31/12/1997 28/02/2009
Hance Fullerton
Hance Fullerton
Chairman - 29/09/2007
Theresa Wallis
Theresa Wallis
Corporate Officer/Principal 31/12/2005 31/12/2005
John Peter Stefano Holden
John Peter Stefano Holden
Corporate Officer/Principal 31/01/2005 -
Charles Buck
Charles Buck
Corporate Officer/Principal - 31/12/2004
David Counts
David Counts
Director/Board Member 31/12/2004 27/08/2009
Corporate Officer/Principal 27/08/2009 -
Stephen James Bates
Stephen James Bates
Chief Executive Officer 31/12/2003 -
Stephen Franklin
Stephen Franklin
Corporate Officer/Principal 31/03/1998 31/08/2002
Shane Booth
Shane Booth
Chief Tech/Sci/R&D Officer 31/12/1996 -
Mark F. DeSantis
Mark F. DeSantis
Corporate Officer/Principal - -
Private Equity Investor 31/12/2004 30/12/2007
Denis Salamon
Denis Salamon
Corporate Officer/Principal 14/11/2010 -
Jothy Rosenberg
Jothy Rosenberg
Director/Board Member - -
Dan O’Shannessy
Dan O’Shannessy
Chief Tech/Sci/R&D Officer - -
Paul Smith
Paul Smith
Corporate Officer/Principal - -

Age distribution of managers

Parity Men Women

Male 9
Female 3

Of which Executive Committee

Male 4
Female 2

Of which Directors

Male 5
Female 1
ESG Refinitiv
-
Logo ANGLE plc
ANGLE plc is a United Kingdom-based liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its circulating tumor cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is a medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for user-validated analysis. Its commercial businesses focus on diagnostic products and clinical services. Its diagnostic products include the Parsortix system and associated consumables. Its services include custom made assay development and clinical trial testing for pharma. The Parsortix technology uses a microfluidic technology in the form of a single use cassette to capture and then harvest CTCs from whole blood.
Employees
0
More about the company

Departures of Key Persons

Stephen James Bates
-
Stephen James Bates

Chief Executive Officer

31/12/2003 -

Hance Fullerton
-
Hance Fullerton

Chairman

- 29/09/2007

Garth Selvey
-
Garth Selvey

Chairman

31/08/2007 21/05/2023